Welcome to our dedicated page for RAYMOND JAMES FINANCIAL SEC filings (Ticker: RJF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on RAYMOND JAMES FINANCIAL's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into RAYMOND JAMES FINANCIAL's regulatory disclosures and financial reporting.
Raymond James Financial reported record fiscal second quarter 2026 results, highlighted by strong revenue and earnings growth. Net revenues reached $3.86 billion, up 13% from a year earlier and 3% sequentially, driven mainly by a 17% increase in asset management and related administrative fees to $2.02 billion and higher investment banking and brokerage revenues.
Net income available to common shareholders was $542 million, or $2.72 per diluted share, up 10% year over year, while adjusted diluted EPS was $2.83. For the first six months, net revenues were $7.59 billion, up 9%, with diluted EPS of $5.51 and adjusted diluted EPS of $5.69, both up 6%. Annualized return on common equity was 17.3% for the quarter and 17.7% year-to-date, with adjusted return on tangible common equity of 20.9%.
The Private Client Group delivered record quarterly net revenues of $2.81 billion and strong domestic net new assets of $23.0 billion, supporting client assets under administration of $1.76 trillion. The Bank segment reported record net loans of $54.8 billion, 14% above March 2025, and a net interest margin of 2.81%. Management noted robust advisor recruiting, a strong investment banking pipeline, and continued investment in technology, including AI integration.
The Vanguard Group filed Amendment No. 14 to a Schedule 13G/A stating it beneficially owns 0 shares of Raymond James Financial Inc. common stock after an internal realignment. The filing cites an internal reorganization effective January 12, 2026 and is signed on 03/27/2026.
The amendment explains certain Vanguard subsidiaries and business divisions will report ownership separately in reliance on SEC Release No. 34-39538, and that The Vanguard Group, Inc. no longer is deemed to beneficially own securities held by those entities.
Raymond James Financial released selected operating data for February 2026, showing continued growth across key wealth and asset metrics. Client assets under administration reached a record $1.83 trillion, up 16% from a year earlier, mainly from higher equity markets and net inflows.
Private Client Group assets under administration rose 16% year-over-year to $1.76 trillion, while assets in fee-based accounts increased 21% to $1.08 trillion, supported by strong advisor recruiting. Financial assets under management grew 16% to $292.5 billion.
Bank loans, net, increased 13% year-over-year to $54.0 billion. Clients’ domestic cash sweep and Enhanced Savings Program balances were $54.6 billion, down 4% from February 2025 and 1% from January 2026. Investment banking revenues for the first two months of the current quarter are approximately 5% above the prior-year comparable period.
Allaire Bella Loykhter reported open-market sale transactions in this Form 4 filing.
Raymond James Financial Chief Admin Officer Bella Loykhter Allaire disposed of 29,551 shares of common stock, valued at $142.34 per share, on March 19, 2026. According to the footnotes, she contributed these shares to an exchange fund and received fund shares in return, using the $142.34 value to calculate the exchange ratio.
After this transaction, she continues to hold 53,586 Raymond James shares directly. She also has an indirect interest in 1,292 shares held through her Employee Stock Ownership Plan account as of March 16, 2026, indicating she retains a substantial equity position in the company.
Raymond James Financial Chief Human Resources Officer Christopher S. Aisenbrey reported equity award activity tied to restricted stock units. On February 28, 2026, he acquired 600 shares of common stock at $0.00 per share through the exercise/conversion of 600 restricted stock units, which vest in tranches through February 28, 2027. To cover associated tax obligations, 132 common shares were disposed of at $153.08 per share, described as a payment of tax liability by delivering securities rather than an open-market sale. After these transactions, he directly owned 17,490 common shares and indirectly held 734 common shares through his Employee Stock Ownership Plan account.
Raymond James Financial director Jeffrey N. Edwards reported two bona fide gifts of common stock. On February 24, 2026, he transferred 1,503.5 shares held directly and 1,503.5 shares held indirectly through his spouse, for a total gift of 3,007 shares. After these transactions, he directly owned 9,533 shares and his spouse indirectly owned 22,008 shares.
Raymond James Financial director Raj Seshadri received an equity grant tied to board service. The filing reports an award of 1,303 Deferred Restricted Stock Units (DRSUs), which vest at the next annual shareholders meeting (but no later than March 15 of the following year). Upon vesting, each DRSU converts into one share of common stock, with additional cash in lieu of dividends, and settlement is deferred until the fifth anniversary of the vest date. Following this grant, Seshadri holds 13,782 common shares, including DRSUs.
Raymond James Financial director Raymond W. McDaniel received an equity-based compensation grant of 1,303 Deferred Restricted Stock Units (DRSUs) on common stock. These DRSUs vest at the date of the next annual shareholders meeting following the grant, but no later than March 15 of the following calendar year.
Each DRSU converts into one share of common stock at settlement, along with cash in lieu of any dividends accrued during the deferral period. According to the filing, settlement is deferred until McDaniel ends his service on the Board of Directors. Following this grant, he holds a total of 6,113 common shares and DRSUs directly.
MCGEARY RODERICK C reported acquisition or exercise transactions in this Form 4 filing.
Roderick C. McGeary, a director of Raymond James Financial Inc., received a grant of 1,303 Deferred Restricted Stock Units (DRSUs) as part of his board compensation. The DRSUs vest at the next annual shareholders meeting (no later than March 15 following grant) and then settle in common shares on a one-to-one basis on the third anniversary of vesting, per his deferral election. After this award, he directly holds a total of 24,354 shares and DRSUs of common stock.
Raymond James Financial director Anne Gates received an equity grant of 1,303 Deferred Restricted Stock Units (DRSUs) as board compensation. Each DRSU will convert into one share of common stock upon vesting, with additional cash in lieu of dividends.
The DRSUs vest at the next annual shareholders meeting following the grant, but no later than March 15 of the following calendar year. Settlement of the vested DRSUs will be deferred until the fifth anniversary of the vest date, in line with Gates’ prior election.